Literature DB >> 4059160

Toxic shock syndrome in Britain--epidemiology and microbiology.

M J de Saxe, P Hawtin, A A Wieneke.   

Abstract

By 30 June 1984, only 99 confirmed and probable cases of toxic shock syndrome (TSS) had been reported in the British Isles. Sixty-three were related to menstruation in women aged 14 to 54 years who used tampons of various brands and absorbencies; 33 (52%) of these cases were in girls under 20. Five women died (8%) and 19 (30%) reported at least one other possible episode. Thirty-six cases associated with a variety of clinical conditions occurred in men aged 17 to 74 years (9), women aged 20 to 54 years (15) and 12 children aged 10 months to 10 years; six patients (17%) died. Strains of Staphylococcus aureus which produced toxic shock syndrome toxin 1 (TSST-1) were isolated from 53 of 58 (91%) menstrual, but only from 18 of 33 (54%) non-menstrual patients. The frequency of toxin production was highest (93%) for 56 vaginal isolates and lowest (33%) for 9 isolates from blood culture. Ninety-six percent (68 of 71) of strains that were TSST-1-positive were sensitive to lytic-group I phages at one of the three concentrations tested; 82% were lysed by phage 29. Nineteen percent of 339 strains from a variety of sources other than TSS, produced TSST-1, and 35% of the strains lysed by group I phages were positive. Antibody to TSST-1 was detected by enzyme-linked immunosorbent assay at a serum dilution of 1:100, in 232 of 320 (82%) healthy individuals aged 14 to 56 years, but in acute-phase sera from only four of 37 (18%) TSS patients. A rise in antibody levels during convalescence was noted in two menstrual and 5 non-menstrual patients. These results show that the epidemiology of TSS is similar in Britain and the United States and provide further evidence of the importance of TSST-1-producing strains in the aetiology of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4059160

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Toxic shock syndrome and sinusitis--a hidden site of infection.

Authors:  J A Griffith; R M Perkin
Journal:  West J Med       Date:  1988-05

2.  Toxic shock syndrome after elective minor dermatological surgery.

Authors:  A R Bosley; N H Bluett; G Sowden
Journal:  BMJ       Date:  1993-02-06

3.  Tampon-induced toxic shock syndrome.

Authors:  S Gupta; A Sahdev; S Forsythe; P Wright; R Wray
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

4.  Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever.

Authors:  S Jarraud; G Cozon; F Vandenesch; M Bes; J Etienne; G Lina
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.

Authors:  Jeffrey Parsonnet; Richard V Goering; Melanie A Hansmann; Michaelle B Jones; Kumiko Ohtagaki; Catherine C Davis; Kyoichi Totsuka
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

6.  Immunohistological localisation of staphylococcal toxic shock syndrome toxin (TSST-1) antigen in sudden infant death syndrome.

Authors:  M J Newbould; J Malam; J M McIllmurray; J A Morris; D R Telford; A J Barson
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

7.  Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.

Authors:  R R Marples; A A Wieneke
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

8.  Non-menstrual associated toxic shock syndrome.

Authors:  P G Murphy; W Holmes; T S Wilson; J P Alexander
Journal:  Ulster Med J       Date:  1987-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.